APA

Rea D. W., Nortier J. W. R., Ten Bokkel Huinink W. W., Falk S., Richel D. J., Maughan T., Groenewegen G., Smit J. M., Steven N., Bakker J. M., Semiond D., Kerr D. J. & Punt C. J. A. (20051004). A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Rea D W, Nortier J W R, Ten Bokkel Huinink W W, Falk S, Richel D J, Maughan T, Groenewegen G, Smit J M, Steven N, Bakker J M, Semiond D, Kerr D J and Punt C J A. 20051004. A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Rea D. W., Nortier J. W. R., Ten Bokkel Huinink W. W., Falk S., Richel D. J., Maughan T., Groenewegen G., Smit J. M., Steven N., Bakker J. M., Semiond D., Kerr D. J. and Punt C. J. A. (20051004). A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Rea D W, Nortier J W R, Ten Bokkel Huinink W W, Falk S, Richel D J, Maughan T, Groenewegen G, Smit J M, Steven N, Bakker J M, Semiond D, Kerr D J and Punt C J A. A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer. : Annals of oncology : official journal of the European Society for Medical Oncology. 20051004.